DekaBank Deutsche Girozentrale
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1456228
FRANKFURT, 2M
Position in REGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$163,186,975
+$162,629 QoQ
Shares Held
211,207
0.0% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DekaBank Deutsche Girozentrale holds $665,183,872 across 48 Biotechnology names. REGN ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
506,457 | $226,153,308 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
211,207 | $163,186,975 | |
| 3 | BNTX |
BioNTech SE
|
481,397 | $42,786,564 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
113,193 | $37,452,167 | |
| 5 | RPRX |
Royalty Pharma plc
|
746,287 | $35,799,386 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
115,130 | $21,765,325 | |
| 7 | EXEL |
Exelixis, Inc.
|
429,690 | $18,429,403 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
280,330 | $15,835,841 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $163,186,975 | 211,207 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $163,024,346 | 211,207 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $118,755,358 | 211,207 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $110,883,675 | 211,207 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $140,276,454 | 221,176 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $150,449,082 | 211,207 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $222,029,245 | 211,207 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $224,735,438 | 213,824 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $212,879,687 | 221,176 | Shares | Defined | 2024-06-04 | |
| 2023-12-31 | $196,899,443 | 224,185 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $164,912,954 | 200,390 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $120,608,376 | 167,852 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $142,716,683 | 173,691 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $123,366,852 | 170,989 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $123,218,176 | 178,870 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $101,209,731 | 171,214 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $105,452,340 | 150,987 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $66,655,040 | 105,547 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $58,410,763 | 96,518 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $46,767,112 | 83,731 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $37,336,423 | 78,912 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $29,124,285 | 60,285 | Shares | Defined | 2021-03-12 | |
| 2020-09-30 | $27,640,256 | 49,377 | Shares | Defined | 2020-10-29 | |
| 2020-06-30 | $8,176,675 | 13,111 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $5,635,354 | 11,541 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||